Literature DB >> 7576233

Expression of full-length human procathepsin L cDNA in Escherichia coli and refolding of the expression product.

M Dolinar1, D B Maganja, V Turk.   

Abstract

From human embrional lung fibroblasts mRNA was obtained and converted to cDNA. The procathepsin L coding region was amplified by PCR, inserted into pALTER and, after checking the nucleotide sequence, transferred into pET81F1+. Procathepsin L was expressed by induction of recombinant E. coli strain BL21[DE3](pLysS) with IPTG and was found to be deposited into inclusion bodies. These were isolated and solubilized in guanidinium hydrochloride. The soluble proteins were sulphonated and procathepsin L was obtained after gel filtration. Purified proenzyme was refolded by dialysis and autoactivated into a form of the expected size and enzymatic activity against a fluorogenic substrate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576233     DOI: 10.1515/bchm3.1995.376.6.385

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  7 in total

1.  Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodes.

Authors:  Valentina Zavasnik-Bergant; Ana Schweiger; Tadeja Bevec; Rastko Golouh; Vito Turk; Janko Kos
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

Review 2.  Approaches for the generation of active papain-like cysteine proteases from inclusion bodies of Escherichia coli.

Authors:  Chunfang Ling; Junyan Zhang; Deqiu Lin; Ailin Tao
Journal:  World J Microbiol Biotechnol       Date:  2015-03-20       Impact factor: 3.312

3.  Stefin B interacts with histones and cathepsin L in the nucleus.

Authors:  Slavko Ceru; Spela Konjar; Katarina Maher; Urska Repnik; Igor Krizaj; Mojca Bencina; Miha Renko; Alain Nepveu; Eva Zerovnik; Boris Turk; Natasa Kopitar-Jerala
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

4.  Redox-based inactivation of cysteine cathepsins by compounds containing the 4-aminophenol moiety.

Authors:  Bojana Mirković; Izidor Sosič; Stanislav Gobec; Janko Kos
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

5.  New inhibitors of cathepsin V impair tumor cell proliferation and elastin degradation and increase immune cell cytotoxicity.

Authors:  Ana Mitrović; Emanuela Senjor; Marko Jukić; Lara Bolčina; Mateja Prunk; Matic Proj; Milica Perišić Nanut; Stanislav Gobec; Janko Kos
Journal:  Comput Struct Biotechnol J       Date:  2022-08-28       Impact factor: 6.155

6.  Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteria.

Authors:  Ilona Bereczki; Vladimir Vimberg; Eszter Lőrincz; Henrietta Papp; Lajos Nagy; Sándor Kéki; Gyula Batta; Ana Mitrović; Janko Kos; Áron Zsigmond; István Hajdú; Zsolt Lőrincz; Dávid Bajusz; László Petri; Jan Hodek; Ferenc Jakab; György M Keserű; Jan Weber; Lieve Naesens; Pál Herczegh; Anikó Borbás
Journal:  Sci Rep       Date:  2022-09-26       Impact factor: 4.996

7.  Identification and characterization of the novel reversible and selective cathepsin X inhibitors.

Authors:  Urša Pečar Fonović; Ana Mitrović; Damijan Knez; Tanja Jakoš; Anja Pišlar; Boris Brus; Bojan Doljak; Jure Stojan; Simon Žakelj; Jurij Trontelj; Stanislav Gobec; Janko Kos
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.